Shanghai MicuRx Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai MicuRx Pharmaceutical has a total shareholder equity of CN¥567.7M and total debt of CN¥229.1M, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are CN¥970.7M and CN¥403.1M respectively.
Key information
40.4%
Debt to equity ratio
CN¥229.12m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥740.30m |
| Equity | CN¥567.65m |
| Total liabilities | CN¥403.10m |
| Total assets | CN¥970.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688373's short term assets (CN¥869.2M) exceed its short term liabilities (CN¥128.0M).
Long Term Liabilities: 688373's short term assets (CN¥869.2M) exceed its long term liabilities (CN¥275.1M).
Debt to Equity History and Analysis
Debt Level: 688373 has more cash than its total debt.
Reducing Debt: 688373 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688373 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 688373 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 21% each year.